Credit: ACI World
The airline industry is bracing for a long winter, but there is light at the end of the tunnel. Airline and travel stocks were boosted recently after two COVID-19 vaccines under development—one from Pfizer and BioNTech, and the other from Moderna—logged initial efficacy rates exceeding 90% in late...
Subscription Required
Daily Memo: Vaccine Trial Successes Shift Recovery Timeline Forward is published in Aviation Daily, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN membership.
Already a member of AWIN or subscribe to Aviation Daily through your company? Login with your existing email and password
Not a member? Learn how to access the market intelligence and data you need to stay abreast of what's happening in the air transport community.
Related Content
